RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

 

Regulatory Focus

EMA backs dexamethasone for COVID-19, seven new medicines and consults on ICH Q3D guideline

21 September 2020 | By Michael Mezher

The European Medicines Agency’s (EMA) on Friday recommended seven medicines for marketing authorization and began a public consultat...

Regulatory Exchange